Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2016-03-31
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thoracic Fluid Assessment by Contrast-enhanced Magnetic Resonance Imaging and Bioimpedance
NCT02364193
Early Passive Verticalization in Critically Ill Patients
NCT02270762
Evaluation of MRI Measures of Lung Water With Posture Changes in Healthy Volunteers and in Patients With Cardiac Failure
NCT01277679
Muscle and Subcutaneous Tissue Variation by Ultrasound and Impedance Linked to Fluid Balance in ICU Patients
NCT06697470
Pneumatic Compression of the Legs to Reduce Fluid Demand in Minor Surgery
NCT01072305
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
neutral position
the patient is in the neutral position, located on his back on a flat surface
CardioScreen 1000 - Haemodynamic Measurement System, Medis
Impedance cardiography (ICG)
SCHILLER, BR-102 plus - Ambulatory Blood Pressure Monitoring System
Blood pressure monitoring every 1 min during leg elevation
legs raised for 20 degrees
patient is placed on a flat surface, legs raised for 20 degrees, supported around ankles
CardioScreen 1000 - Haemodynamic Measurement System, Medis
Impedance cardiography (ICG)
SCHILLER, BR-102 plus - Ambulatory Blood Pressure Monitoring System
Blood pressure monitoring every 1 min during leg elevation
legs raised for 30 degrees
patient is placed on a flat surface, legs raised for 30 degrees, supported around ankles
CardioScreen 1000 - Haemodynamic Measurement System, Medis
Impedance cardiography (ICG)
SCHILLER, BR-102 plus - Ambulatory Blood Pressure Monitoring System
Blood pressure monitoring every 1 min during leg elevation
legs raised for 45 degrees
patient is placed on a flat surface, legs raised for 45 degrees, supported around ankles
CardioScreen 1000 - Haemodynamic Measurement System, Medis
Impedance cardiography (ICG)
SCHILLER, BR-102 plus - Ambulatory Blood Pressure Monitoring System
Blood pressure monitoring every 1 min during leg elevation
legs raised for 60 degrees
patient is placed on a flat surface, legs raised for 60 degrees, supported around ankles
CardioScreen 1000 - Haemodynamic Measurement System, Medis
Impedance cardiography (ICG)
SCHILLER, BR-102 plus - Ambulatory Blood Pressure Monitoring System
Blood pressure monitoring every 1 min during leg elevation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CardioScreen 1000 - Haemodynamic Measurement System, Medis
Impedance cardiography (ICG)
SCHILLER, BR-102 plus - Ambulatory Blood Pressure Monitoring System
Blood pressure monitoring every 1 min during leg elevation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no clinical cardiovascular disease during the 6 months proceeding entry
Exclusion Criteria
* episode of illness (for example: infection)
* pregnancy
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Warsaw
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Łukasz Szarpak
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lukasz Szarpak, PhD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Warsaw
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Warsaw, Department of Emergency Medicine
Warsaw, Masovia, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
02.014.1MR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.